MedPath

Bupsan

Brand Name: Bupsan

Generic Name: Bupivacaine Hydrochloride

Active
Registration Number

DRP-8777

Dosage Form

Solution for Intrathecal Injection

Issuance Date

January 31, 2023

Expiry Date

December 28, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg/mL (0.5% w/v)
PackagingUSP Type I clear glass ampoule x 5 mL & 10 mL (net content) Box of 5's and 1's

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial (Variation) (Reconstructed)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Bupivacaine HydrochlorideActive
Monograph: Bupivacaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform